| | 202409-33-4 Basic information More.. |
| Product Name: | Etoricoxib | | Synonyms: | Etoricoxib Solution, 100ppm;Etoricoxib(5-chloro-6'-Methyl-3-(4-(Methylsulfonyl)phenyl)-2,3'-bipyridine;Etoricoxib (200 mg);Etoricoxib impurity A;Etoricoxib, >=98%;5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine;ETORICOXIB;5-Chloro-6'-methyl-3-[4-(methylsulfonyl) phenyl]-2,3'-bipyridine | | CAS: | 202409-33-4 | | MF: | C18H15ClN2O2S | | MW: | 358.84 | | EINECS: | 682-421-5 | | Mol File: | 202409-33-4.mol |  |
Use
Etoricoxib is a dipyridinyl compound that demonstrates high in vitro and ex vivo selectivity for COX-2 over COX-1 in several assays, e.g., in the production of PGE2 by CHO cells expressing either COX-2 (IC50 = 79 nM) or COX-1 (IC50 > 50 μM). Oral etoricoxib is well absorbed and metabolized extensively via oxidation, with metabolites excreted largely in the urine.
- Etoricoxib
-
- 2025-05-10
- CAS:202409-33-4
- Min. Order:
- Purity: 0.99
- Supply Ability:
- Etoricoxib
-
- US $0.00-0.00 / kg
- 2025-05-09
- CAS:202409-33-4
- Min. Order: 1kg
- Purity: 98
- Supply Ability: 500
- Etoricoxib
-
- US $0.00-0.00 / Kg/Drum
- 2025-05-09
- CAS:202409-33-4
- Min. Order: 1KG
- Purity: 98%min
- Supply Ability: 100kgs
|
|
202409-33-4
Recommend Suppliers |
|